Reinforced Pancreaticojejunostomy With or Without glubran2
Recruiting
Phase 2
Interventional Study
Pancreatic Fistula
Pancreas Cancer
Periampullary Carcinoma
Pancreatic Ductal Adenocarcinoma
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 – 75
- Sex
- Any
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 100 (estimated)
- Sponsor
- Minia University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Pancreatic fistula is one of the most serious complication after pancreatoduodenectomy. To reduce pancreatic fistula, many authors recommend different techniques in pancreatojejunostomy. The purpose of this study is to determine which is the best method in preventing pancreatic fistula by enforce pancreaticojejunostomy with tissue glue .
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* All the patients undergoing pancreaticoduodenectomy for cancer
* Patients able to give their informed consent
Exclusion Criteria:
* Unfit patients for surgery due to severe medical illness.
* Inoperable patients by imaging studies, irresectable tumors after laparotomy or dia…
Contacts